552 related articles for article (PubMed ID: 32862390)
21. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
[TBL] [Abstract][Full Text] [Related]
22. Identification of key genes and signalling pathways in clear cell renal cell carcinoma: An integrated bioinformatics approach.
S V; Balasubramanian S; Perumal E; Santhakumar K
Cancer Biomark; 2024; 40(1):111-123. PubMed ID: 38427469
[TBL] [Abstract][Full Text] [Related]
23. ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma.
Xu T; Ruan H; Gao S; Liu J; Liu Y; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Shi J; Liang H; Yang H; Chen K; Zhang X
Aging (Albany NY); 2020 Jan; 12(2):1808-1827. PubMed ID: 32003757
[TBL] [Abstract][Full Text] [Related]
24. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract][Full Text] [Related]
25. NUF2 is correlated with a poor prognosis and immune infiltration in clear cell renal cell carcinoma.
Zheng B; Wang S; Yuan X; Zhang J; Shen Z; Ge C
BMC Urol; 2023 May; 23(1):82. PubMed ID: 37138262
[TBL] [Abstract][Full Text] [Related]
26. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma.
Xie C; Yiu W; Mo Y
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144
[TBL] [Abstract][Full Text] [Related]
28. Clear Cell Renal Cell Carcinoma: A Comprehensive in silico Study in Searching for Therapeutic Targets.
Naghdibadi M; Momeni M; Yavari P; Gholaminejad A; Roointan A
Kidney Blood Press Res; 2023; 48(1):135-150. PubMed ID: 36854280
[TBL] [Abstract][Full Text] [Related]
29. Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccRCC) by Transcriptomics.
Zhang S; Xu X; Wang Y; Zhu Y; Wang J; Wang H; Guo J
Ann Clin Lab Sci; 2021 Sep; 51(5):597-608. PubMed ID: 34686501
[TBL] [Abstract][Full Text] [Related]
30. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
Wan B; Liu B; Huang Y; Lv C
Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
[TBL] [Abstract][Full Text] [Related]
31. Identifying hub genes of clear cell renal cell carcinoma associated with the proportion of regulatory T cells by weighted gene co-expression network analysis.
Chen YH; Chen SH; Hou J; Ke ZB; Wu YP; Lin TT; Wei Y; Xue XY; Zheng QS; Huang JB; Xu N
Aging (Albany NY); 2019 Oct; 11(21):9478-9491. PubMed ID: 31672930
[TBL] [Abstract][Full Text] [Related]
32. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
Luo L; Zhou H; Su H
BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
[TBL] [Abstract][Full Text] [Related]
33. Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.
Chen D; Chen W; Xu Y; Zhu M; Xiao Y; Shen Y; Zhu S; Cao C; Xu X
J Med Genet; 2019 Jan; 56(1):43-49. PubMed ID: 29967134
[TBL] [Abstract][Full Text] [Related]
34. Differential expression analysis identifies a prognostically significant extracellular matrix-enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma.
Jokelainen O; Rintala TJ; Fortino V; Pasonen-Seppänen S; Sironen R; Nykopp TK
Sci Rep; 2024 May; 14(1):10626. PubMed ID: 38724670
[TBL] [Abstract][Full Text] [Related]
35. Exploring the mechanism of clear cell renal cell carcinoma metastasis and key genes based on multi-tool joint analysis.
Yang H; Li W; Lv Y; Fan Q; Mao X; Long T; Xie L; Dong C; Yang R; Zhang H
Gene; 2019 Dec; 720():144103. PubMed ID: 31491435
[TBL] [Abstract][Full Text] [Related]
36. Identification of Biomarkers Associated With Pathological Stage and Prognosis of Clear Cell Renal Cell Carcinoma by Co-expression Network Analysis.
Chen L; Yuan L; Qian K; Qian G; Zhu Y; Wu CL; Dan HC; Xiao Y; Wang X
Front Physiol; 2018; 9():399. PubMed ID: 29720944
[TBL] [Abstract][Full Text] [Related]
37. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
[TBL] [Abstract][Full Text] [Related]
38. Analysis and verification of
Yang Z; Peng B; Pan Y; Gu Y
Bioengineered; 2021 Dec; 12(2):9473-9483. PubMed ID: 34699322
[No Abstract] [Full Text] [Related]
39. Identification and Verification of Biomarker in Clear Cell Renal Cell Carcinoma via Bioinformatics and Neural Network Model.
Liu B; Xiao Y; Li H; Zhang AL; Meng LB; Feng L; Zhao ZH; Ni XC; Fan B; Zhang XY; Zhao SB; Liu YB
Biomed Res Int; 2020; 2020():6954793. PubMed ID: 32626756
[TBL] [Abstract][Full Text] [Related]
40. Integrated Analysis of Three Publicly Available Gene Expression Profiles Identified Genes and Pathways Associated with Clear Cell Renal Cell Carcinoma.
Han Y; Wang L; Wang Y
Med Sci Monit; 2020 Jul; 26():e919965. PubMed ID: 32712616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]